These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8820822

  • 1. The somatostatin analog angiopeptin does not reduce chronic hypoxic pulmonary hypertension in rats.
    Sidney EJ, Hampl V, Nelson DP, Archer SL, Foegh ML, Cathapermal SS, Weir EK.
    Proc Soc Exp Biol Med; 1996 Oct; 213(1):43-9. PubMed ID: 8820822
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of somatostatin and angiopeptin on cell proliferation.
    Alderton F, Lauder H, Feniuk W, Fan TP, Humphrey PP.
    Br J Pharmacol; 1998 May; 124(2):323-30. PubMed ID: 9641549
    [Abstract] [Full Text] [Related]

  • 3. Chronic hypoxic pulmonary hypertension. Is thrombin involved?
    Hampl V, Archer SL, Bach R, Nelson DP, Weir EK.
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1043-8. PubMed ID: 8214923
    [Abstract] [Full Text] [Related]

  • 4. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619.
    Zhao Y, Foegh ML.
    Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208
    [Abstract] [Full Text] [Related]

  • 5. Specific N-terminal CGRP fragments mitigate chronic hypoxic pulmonary hypertension in rats.
    Qing X, Wimalawansa SJ, Keith IM.
    Regul Pept; 2003 Jan 31; 110(2):93-9. PubMed ID: 12527141
    [Abstract] [Full Text] [Related]

  • 6. Angiopeptin, a somatostatin-14 analogue, decreases adhesiveness of rat leukocytes to unstimulated and IL-1 beta-activated rat heart endothelial cells.
    Leszczynski D, Dunsky K, Josephs MD, Zhao Y, Foegh ML.
    Life Sci; 1995 Jan 31; 57(15):PL217-23. PubMed ID: 7674827
    [Abstract] [Full Text] [Related]

  • 7. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats.
    Chen SJ, Chen YF, Meng QC, Durand J, Dicarlo VS, Oparil S.
    J Appl Physiol (1985); 1995 Dec 31; 79(6):2122-31. PubMed ID: 8847282
    [Abstract] [Full Text] [Related]

  • 8. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure.
    Hampl V, Archer SL, Nelson DP, Weir EK.
    J Appl Physiol (1985); 1993 Oct 31; 75(4):1748-57. PubMed ID: 7506706
    [Abstract] [Full Text] [Related]

  • 9. Attenuation of chronic hypoxic pulmonary hypertension by simvastatin.
    Girgis RE, Li D, Zhan X, Garcia JG, Tuder RM, Hassoun PM, Johns RA.
    Am J Physiol Heart Circ Physiol; 2003 Sep 31; 285(3):H938-45. PubMed ID: 12750068
    [Abstract] [Full Text] [Related]

  • 10. Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats.
    Klinger JR, Warburton RR, Pietras L, Hill NS.
    J Appl Physiol (1985); 1998 May 31; 84(5):1646-52. PubMed ID: 9572812
    [Abstract] [Full Text] [Related]

  • 11. Angiopeptin inhibits thymidine incorporation by explants of porcine coronary arteries.
    Vargas R, Wroblewska B, Rego A, Cathapermal S, Ramwell PW.
    J Cardiovasc Pharmacol; 1997 Feb 31; 29(2):278-83. PubMed ID: 9057079
    [Abstract] [Full Text] [Related]

  • 12. Angiopeptin, the octapeptide analogue of somatostatin, decreases rat heart endothelial cell adhesiveness for mononuclear cells.
    Leszczynski D, Josephs MD, Fournier RS, Foegh ML.
    Regul Pept; 1993 Feb 18; 43(3):131-40. PubMed ID: 8095098
    [Abstract] [Full Text] [Related]

  • 13. Prolonged nitric oxide inhalation fails to regress hypoxic vascular remodeling in rat lung.
    Jiang BH, Maruyama J, Yokochi A, Iwasaki M, Amano H, Mitani Y, Maruyama K.
    Chest; 2004 Jun 18; 125(6):2247-52. PubMed ID: 15189948
    [Abstract] [Full Text] [Related]

  • 14. The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit.
    Hong MK, Bhatti T, Matthews BJ, Stark KS, Cathapermal SS, Foegh ML, Ramwell PW, Kent KM.
    Circulation; 1993 Aug 18; 88(2):638-48. PubMed ID: 8101773
    [Abstract] [Full Text] [Related]

  • 15. Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism.
    Li J, Zhang P, Zhang QY, Zhang SM, Guo HT, Bi H, Wang YM, Sun X, Liu JC, Cheng L, Cui Q, Yu SQ, Kaye AD, Yi DH, Pei JM.
    Vascul Pharmacol; 2009 Aug 18; 51(2-3):72-7. PubMed ID: 19351568
    [Abstract] [Full Text] [Related]

  • 16. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
    Ono S, Westcott JY, Voelkel NF.
    J Appl Physiol (1985); 1992 Sep 18; 73(3):1084-92. PubMed ID: 1400021
    [Abstract] [Full Text] [Related]

  • 17. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.
    Hong MK, Kent KM, Mehran R, Mintz GS, Tio FO, Foegh M, Wong SC, Cathapermal SS, Leon MB.
    Circulation; 1997 Jan 21; 95(2):449-54. PubMed ID: 9008463
    [Abstract] [Full Text] [Related]

  • 18. CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension.
    Tjen-A-Looi S, Ekman R, Lippton H, Cary J, Keith I.
    Am J Physiol; 1992 Sep 21; 263(3 Pt 2):H681-90. PubMed ID: 1357980
    [Abstract] [Full Text] [Related]

  • 19. Reduction of chronic hypoxic pulmonary hypertension in the rat by beta-aminopropionitrile.
    Kerr JS, Riley DJ, Frank MM, Trelstad RL, Frankel HM.
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Dec 21; 57(6):1760-6. PubMed ID: 6511550
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary vascular adaptations to augmented polycythemia during chronic hypoxia.
    Petit RD, Warburton RR, Ou LC, Hill NS.
    J Appl Physiol (1985); 1995 Jul 21; 79(1):229-35. PubMed ID: 7559224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.